Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Berger
    Berger
  2. Ladanyi
    Ladanyi
  3. Arcila
    Arcila
  4. Nafa
    Nafa
  5. Shah
    Shah
  6. Hameed
    Hameed
  7. Solit
    Solit
  8. Schultz
    Schultz
  9. Dogan
    Dogan
  10. Bajorin
    Bajorin

Groups

  1. GSK Faculty (42)
  2. Human Oncology and Pathogenesis Program (42)
  3. Tow Center for Developmental Oncology (TCDO) (25)
  4. Department of Medicine (21)
  5. Solid Tumor Oncology Division (17)
  6. Center for Pancreatic Cancer Research (9)
  7. Genitourinary Oncology Service (9)
  8. Epidemiology and Biostatistics (8)
  9. Surgery (8)
  10. Breast Medicine Service (7)
Search Within
  1. "Michael Berger"
Formats
  1. Meeting Abstract (27)
  2. Journal Article (14)
  3. Editorial (1)
Groups
  1. GSK Faculty (42)
  2. Human Oncology and Pathogenesis Program (42)
  3. Tow Center for Developmental Oncology (TCDO) (25)
  4. Department of Medicine (21)
  5. Solid Tumor Oncology Division (17)
  6. Center for Pancreatic Cancer Research (9)

More Groups

People
  1. Michael Berger (42)
  2. Ahmet Zehir (29)
  3. Marc Ladanyi (25)
  4. Maria Arcila (25)
  5. Khedoudja Nafa (16)
  6. Donavan Cheng (15)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (1)
  4. 2021 (2)
  5. 2020 (1)
  6. 2019 (3)

More Years

Publications
  1. Journal of Molecular Diagnostics (34)
  2. European Urology (5)
  3. Journal of the American College of Surgeons (1)
  4. Lancet (1)
  5. Lancet Oncology (1)

Results (42)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study
    Journal Article

    Tsai, C. J.; Yang, J. T.; Shaverdian, N.; Patel, J.; Shepherd, A. F.; Eng, J.; Guttmann, D.; Yeh, R.; Gelblum, D. Y.; Namakydoust, A.; more...
    Lancet (2024)

    Fulltext@MSK | Save
  • Validation of an ultra-sensitive genomic NGS assay for hematological malignancies
    Meeting Abstract

    DiNapoli, S. E.; Gedvilaite, E.; Bowman, A.; Xu, F.; Parikh, A. D.; Diosdado, M.; Cassanova-Murphy, J.; Rana, S.; Haque, M. H.; Hale, C.; more...
    Journal of Molecular Diagnostics (2023)

    Fulltext@MSK | Save
  • First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: A single-arm, single-centre, phase 2 trial
    Journal Article

    Cytryn, S. L.; Moy, R. H.; Cowzer, D.; Shah, R. H.; Chou, J. F.; Joshi, S. S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • Defining novel DNA virus-tumor associations and genomic correlates using prospective clinical tumor/normal matched sequencing data
    Journal Article

    Vanderbilt, C. M.; Bowman, A. S.; Middha, S.; Petrova-Drus, K.; Tang, Y. W.; Chen, X.; Wang, Y.; Chang, J.; Rekhtman, N.; Busam, K. J.; more...
    Journal of Molecular Diagnostics (2022)

    Fulltext@MSK | Save
  • Clinical experience of cerebrospinal fluid-based liquid biopsy demonstrates superiority of cell-free DNA over cell pellet genomic DNA for molecular profiling
    Journal Article

    Bale, T. A.; Yang, S. R.; Solomon, J. P.; Nafa, K.; Middha, S.; Casanova, J.; Sadowska, J.; Skakodub, A.; Ahmad, H.; Yu, H. A.; more...
    Journal of Molecular Diagnostics (2021)

    Fulltext@MSK | Save
  • A pan-cancer study of somatic TERT promoter mutations and amplification in 30,773 tumors profiled by clinical genomic sequencing
    Journal Article

    Gupta, S.; Vanderbilt, C. M.; Lin, Y. T.; Benhamida, J. K.; Jungbluth, A. A.; Rana, S.; Momeni-Boroujeni, A.; Chang, J. C.; Mcfarlane, T.; Salazar, P.; more...
    Journal of Molecular Diagnostics (2021)

    Fulltext@MSK | Save
  • Noninvasive genomic profiling of 113 patients with advanced renal cell carcinoma
    Meeting Abstract

    Gedvilaite, E.; Kotecha, R.; Murray, S.; Foster, A.; Motzer, R.; Ptashkin, R.; Johnson, I.; Shah, R.; Dunigan, M.; Huberman, K.; more...
    Journal of Molecular Diagnostics (2020)

    Fulltext@MSK | Save
  • Integrated germline and somatic analysis identifies actionable cancer predisposing germline mutations in 9,734 patients with advanced cancers
    Meeting Abstract

    Jayakumaran, G.; Mandelker, D.; Birsoy, O.; Jairam, S.; Li, Y.; Yang, C.; Somar, J.; Rai, V.; Syed, A.; Benayed, R.; more...
    Journal of Molecular Diagnostics (2019)

    Fulltext@MSK | Save
  • Next-generation sequencing–based assessment of JAK2, PD-L1, and PD-L2 copy number alterations at 9p24.1 in breast cancer: Potential implications for clinical management
    Journal Article

    Gupta, S.; Vanderbilt, C. M.; Cotzia, P.; Arias-Stella, J. A. 3rd; Chang, J. C.; Zehir, A.; Benayed, R.; Nafa, K.; Razavi, P.; Hyman, D. M.; more...
    Journal of Molecular Diagnostics (2019)

    Fulltext@MSK | Save
  • Genomic differences between “primary” and “secondary” muscle-invasive bladder cancer as a basis for disparate outcomes to cisplatin-based neoadjuvant chemotherapy
    Editorial

    Pietzak, E. J.; Zabor, E. C.; Bagrodia, A.; Armenia, J.; Hu, W.; Zehir, A.; Funt, S.; Audenet, F.; Barron, D.; Maamouri, N.; more...
    European Urology (2019)

    Fulltext@MSK | Save